Nucleate RI | PATH:Inside AI in Biotech
Event Overview:
Nucleate Rhode Island’s AI in Biotech panel is designed to engage life science innovators in conversations about the current state and future directions of using artificial intelligence for biotechnological advancements. From data infrastructure to translational strategy and commercial execution, we’ll explore where AI is genuinely transforming the field, and where the hype still outpaces the science. Hear from experts across research, venture creation, and commercial leadership who have navigated this landscape firsthand, and leave with a clearer sense of how to position yourself at the forefront of this rapidly evolving field.
Panelists:
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta